Silo Pharma (SILO) Total Current Liabilities (2011 - 2026)
Silo Pharma (SILO) posted Total Current Liabilities of $704845.0 for Q1 2026, up 8.41% sequentially from $650183.0 in Q4 2025, and down 40.53% YoY from $1.2 million in Q1 2025.
Silo Pharma (SILO) Total Current Liabilities (2011 - 2026) Analysis & Trends
Silo Pharma has reported Total Current Liabilities for 13 years, with the latest figure at $704845.0 in Q1 2026.
- Quarterly Total Current Liabilities fell 40.53% year-over-year to $704845.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $704845.0 (down 40.53% YoY) and the FY2025 annual result came in at $650183.0, down 60.74% from the prior year.
- Total Current Liabilities improved to $704845.0 in Q1 2026 per SILO's latest filing, from $650183.0 in the prior quarter.
- Over five years, Total Current Liabilities peaked at $1.7 million in Q4 2024 and troughed at $268845.0 in Q2 2022.
- A 5-year average of $812528.6 and a median of $732381.0 in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities jumped 316.67% in 2023, then tumbled 60.74% in 2025.
- Over 5 years, Total Current Liabilities stood at $436318.0 in 2022, then surged by 77.76% to $775590.0 in 2023, then jumped by 113.51% to $1.7 million in 2024, then sank by 60.74% to $650183.0 in 2025, then grew by 8.41% to $704845.0 in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $704845.0, $650183.0, and $708339.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 630.93 Mn |
| 10 | Silo Pharma | 3.08 Mn | 3.08 Mn | - | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 704,845.00 |
| Dec 31, 2025 | 650,183.00 |
| Sep 30, 2025 | 708,339.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 873,672.00 |
| Dec 31, 2023 | 775,590.00 |
| Sep 30, 2023 | 678,771.00 |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 732,381.00 |
| Dec 31, 2022 | 436,318.00 |
| Sep 30, 2022 | 312,194.00 |
| Jun 30, 2022 | 268,845.00 |
| Mar 31, 2022 | 292,748.00 |
| Dec 31, 2021 | 490,039.00 |
| Sep 30, 2021 | 283,389.00 |